These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 2981181)

  • 1. The antilipolytic effect of insulin does not require adenylate cyclase or phosphodiesterase action.
    Gabbay RA; Lardy HA
    FEBS Lett; 1985 Jan; 179(1):7-11. PubMed ID: 2981181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of N6-(L-2-phenylisopropyl)adenosine and insulin on cAMP metabolism in 3T3-L1 adipocytes.
    Elks ML; Jackson M; Manganiello VC; Vaughan M
    Am J Physiol; 1987 Mar; 252(3 Pt 1):C342-8. PubMed ID: 3030132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of the age-related decrease of epinephrine-stimulated lipolysis in isolated rat adipocytes: beta-adrenergic receptor binding, adenylate cyclase activity, and cyclic AMP accumulation.
    Dax EM; Partilla JS; Gregerman RI
    J Lipid Res; 1981 Aug; 22(6):934-43. PubMed ID: 6268727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of two phosphodiesterase inhibitors on fat cell metabolism.
    Shechter Y
    Endocrinology; 1984 Nov; 115(5):1787-91. PubMed ID: 6208014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antilipolytic effect of insulin in human adipocytes requires activation of the phosphodiesterase.
    Lönnroth P; Smith U
    Biochem Biophys Res Commun; 1986 Dec; 141(3):1157-61. PubMed ID: 2434081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of partially purified NSILA on adenylate cyclase, phosphodiesterase and 3',5'-cyclic AMP in fat cells.
    Hepp KD; Renner R; Langley J; Häring HU
    Mol Cell Endocrinol; 1975 Oct; 3(4):309-21. PubMed ID: 172393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of adenosine 3',5'-monophosphate and the Ri-receptor Gi-coupled adenylate cyclase inhibitory pathway in the mechanism whereby adrenalectomy increases the adenosine antilipolytic effect in rat fat cells.
    de Mazancourt P; Lacasa D; Giot J; Giudicelli Y
    Endocrinology; 1989 Mar; 124(3):1131-9. PubMed ID: 2465135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antilipolytic action of insulin: role of cAMP phosphodiesterase activation.
    Elks ML; Manganiello VC
    Endocrinology; 1985 May; 116(5):2119-21. PubMed ID: 2985373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of different phosphodiesterase inhibitors on the antilipolytic action of insulin in human adipocytes.
    Kather H; Scheurer A
    Horm Metab Res; 1987 Aug; 19(8):379-81. PubMed ID: 2822563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytes.
    Litosch I; Hudson TH; Mills I; Li SY; Fain JN
    Mol Pharmacol; 1982 Jul; 22(1):109-15. PubMed ID: 6289066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N6-(Phenylisopropyl)adenosine prevents glucagon both blocking insulin's activation of the plasma-membrane cyclic AMP phosphodiesterase and uncoupling hormonal stimulation of adenylate cyclase activity in hepatocytes.
    Wallace AV; Heyworth CM; Houslay MD
    Biochem J; 1984 Aug; 222(1):177-82. PubMed ID: 6089755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of insulin-sensitive phosphodiesterase in insulin action.
    Makino H; Suzuki T; Kajinuma H; Yamazaki M; Ito H; Yoshida S
    Adv Second Messenger Phosphoprotein Res; 1992; 25():185-99. PubMed ID: 1372810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive but reversible depletion of ATP via adenylate cyclase in rat adipocytes.
    Chung FZ; Weber HW; Appleman MM
    Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1614-7. PubMed ID: 3856840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone-sensitive cyclic GMP-inhibited cyclic AMP phosphodiesterase in rat adipocytes. Regulation of insulin- and cAMP-dependent activation by phosphorylation.
    Smith CJ; Vasta V; Degerman E; Belfrage P; Manganiello VC
    J Biol Chem; 1991 Jul; 266(20):13385-90. PubMed ID: 1649189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6-phenylisopropyladenosine stimulates in normal and inhibits in adrenalectomized rats the low KM cyclic AMP phosphodiesterase in the brain.
    de Mazancourt P; Giudicelli Y
    Brain Res; 1984 May; 300(2):211-7. PubMed ID: 6329432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin stimulation of cyclic AMP phosphodiesterase is independent from the G-protein pathways involved in adenylate cyclase regulation.
    Weber HW; Chung FZ; Day K; Appleman MM
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):345-54. PubMed ID: 3040818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis toxin reversal of the antilipolytic action of insulin in rat adipocytes in the presence of forskolin does not involve cyclic AMP.
    Mills I; Fain JN
    Biochem Biophys Res Commun; 1985 Aug; 130(3):1059-65. PubMed ID: 2992496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of basal and hormone-stimulated adenylate cyclase in adipocyte ghosts by the prostaglandin endoperoxide prostaglandin H2.
    Gorman RR; Hamberg M; Samuelsson B
    J Biol Chem; 1975 Aug; 250(16):6460-3. PubMed ID: 169245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal control of cyclic AMP turnover in isolated fat cells.
    Häring HU; Renner R; Hepp KD
    Mol Cell Endocrinol; 1976; 5(3-4):295-302. PubMed ID: 182581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.